Can a traditional chinese herb boost IVF success?

NCT ID NCT07641088

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether Zishen Yutai Pill, a traditional Chinese herbal medicine, can improve live birth rates in women who have had repeated failure to implant embryos after IVF. About 878 women aged 20-40 will receive either the pill or a placebo before and after frozen embryo transfer. The goal is to see if the pill increases the chance of a successful pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Zishen Yutai Pill (herbal medicine)
What this could lead to
If it works, this could offer a new option to improve pregnancy success for women who have repeatedly failed to implant embryos after IVF.
What could go wrong
This is an early-stage trial with no phase specified, and the herbal pill may not outperform placebo. Results may not apply to all fertility patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT IMPLANTATION FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, China

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China

  • Peking University Third Hospital

    Beijing, Beijing Municipality, 100191, China

  • Shanghai Ninth People's Hospital

    Shanghai, Shanghai Municipality, China

  • Sichuan Jinxin Xinan Women and Children's Hospital (Bisheng)

    Chengdu, Sichuan, China

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, Anhui, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaanxi, China

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.